Macrogenics Overview
Macrogenics Target Price
Explore Macrogenics's target price with historical charts and peer comparisons.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.08
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-20 | Barclays | $6 |  47.1% upside |  |
| 2025-05-14 | BarclaysPeter Lawson | $3 |  26.5% downside | |
| 2025-03-25 | H.C. Wainwright | $2 | 51% downside | |
| 2024-08-07 | Stifel NicolausStephen Willey | $6 | 47.1% upside | |
| 2024-07-31 | JMP SecuritiesSilvan Tuerkcan | $8 | 96.1% upside | |
| 2024-07-31 | B.Riley FinancialMayank Mamtani | $5 | 22.5% upside | |
| 2024-07-29 | BarclaysPeter Lawson | $9 | 120.6% upside | |
| 2024-05-23 | BTIGKaveri Pohlman | $9 | 120.6% upside | |
| 2024-05-13 | H.C. WainwrightDebjit Chattopadhyay | $4 | 2% downside | |
| 2024-05-10 | BarclaysPeter Lawson | $14 | 243.1% upside | |
| 2024-05-10 | BMO CapitalEtzer Darout | $8 | 96.1% upside | |
| 2024-04-04 | Stifel NicolausStephen Willey | $29 | 610.8% upside | |
| 2022-11-22 | GuggenheimCharles Zhu | $12 | 194.1% upside | |
| 2022-07-11 | BTIGKaveri Pohlman | $6 | 47.1% upside | |
| 2021-06-16 | WedbushDavid Nierengarten | $32 | 684.3% upside | |